Month: July 2022

COCONUT CREEK, FL, July 08, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – NutraLife Biosciences Inc. (OTC: NLBS), a manufacturer and distributor of private label and branded nutraceutical and skincare products, today announced it has executed a joint venture agreement with Emergent Health Corp. (“Emergent”) (OTC: EMGE) for the co-production, co-marketing, and distribution of Emergent’s line of regenerative, and other health-related nutraceutical products. Nutralife is a developer, manufacturer, and distributor of various nutraceutical and skincare products with more than 50 different products and formulations. NutraLife products are made with the finest, most effective ingredients, some of which include CBD. These products by design support and cater to a multitude of health and wellness applications to help and improve one’s quality...

Key patent strengthens proprietary position in China until August 2031 NEWTON, Mass. and GENEVA, July 08, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER) (Acer) and its collaboration partner, RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief), today announced that the China National Intellectual Property Administration (CNIPA) issued Electronic Patent Certificate ZL202122004991.9 on May 24, 2022, for Utility Model directed to ACER-001 (sodium phenylbutyrate). Specifically, the newly issued patent covers dosage form claims related to ACER-001’s polymer coated formulation for oral administration as a potential treatment for urea cycle disorders (UCDs) and Maple Syrup Urine Disease (MSUD). The newly issued patent has an expiration date of August 24, 2031. “The receipt of this patent from the CNIPA...

WOODSIDE, Calif., July 08, 2022 (GLOBE NEWSWIRE) — Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that it will release its second quarter 2022 financial results after market close on Thursday, August 4, 2022. Runway Growth will discuss its financial results on a conference call that day at 3:00 p.m. PT (6:00 p.m. ET). To participate in the conference call or webcast, participants should register online at the Runway Growth Investor Relations website. Participants are requested to register a day in advance or at a minimum 15 minutes before the start of the call. The earnings call can also be accessed through the following links:Conference Call WebcastA replay of the webcast...

Several New Directors are Named as the Company Seeks to Qualify for Uplisting with This Important Milestone FORT LAUDERDALE, FL, July 08, 2022 (GLOBE NEWSWIRE) — SFLMaven Corp. (OTC Pink: SFLM), (“SFLMaven” or the “Company”) (www.sflmaven.com), a leading provider of high-end luxury goods, recently announced its plans to begin the process of preparing the company for uplisting and acquisitions. See the previous PR Here: SFLM Press Release 2022/06/22. Now, the company focuses on forming and finalizing an independent board of directors. By forming an independent board of directors, the company will tackle a significant milestone towards qualifying for an uplisting to a higher OTC Market Tier such as OTC: QB or, for the potential uplist to NASDAQ with an S1 IPO type funding round. CEO Joseph Ladin said: “We...

SAN FRANCISCO, July 08, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today provided comment on the recently released Centers for Medicare and Medicaid Services (“CMS”) Medicare Physician Fee Schedule Proposed Rule for Calendar Year 2023 (the “Proposed Rule”). The Proposed Rule was released on July 7, 2022 and proposes to update the payment rates and other provisions for services furnished on or after January 1, 2023 and reimbursed under the Medicare Physician Fee Schedule (“MPFS”). The Proposed Rule is followed by a public comment period which will culminate with CMS’ release of a Final Rule, which is expected to be announced by early November for implementation on January 1, 2023. The policies announced in the Proposed...

The New Desktop Privacy Solution Prevents a User’s Personal Data, Online Activity and History from Being Accessed or Monitored by Internet Service Providers, Advertisers and Third Parties HERZLIYA, Israel, July 08, 2022 (GLOBE NEWSWIRE) — Safe-T Group Ltd. (Nasdaq: SFET) (TASE: SFET) (“Safe-T” or the “Company”), a global provider of cyber-security and privacy solutions for consumers and enterprises, today announced its entrance into the home computer market with the release of its first consumer privacy solution designed for Windows personal computers (“PCs”). Building upon the success and best-of-breed technology of its iOS privacy solution currently helping protect thousands of mobile devices, Safe-T is expanding its offerings into the global Windows PC market. Today, with approximately 50% of worldwide data traffic originating...

TEL AVIV, Israel, July 08, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced it has started the process of preparing for an Investigational New Drug Application (“IND”) with the U.S. Food and Drug Administration (“FDA”) for its Phase IIb clinical trial for SCI-110 in patients suffering from Tourette Syndrome (“TS”). The work towards an IND submission is intended to open a U.S. clinical site that will take part in the phase IIb trial. “We are very excited about expanding our clinical sites to the U.S., especially after positive results obtained in a clinical trial led by Prof. Bloch M.D., M.S., an associate Professor...